← Back to Search

Messaging Strategies for Vaccine Hesitancy

N/A

Waitlist Available

Led By Carl A Latkin, Ph.D.

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have heard of COVID-19 and the COVID-19 vaccine

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial will develop and test interventions to encourage people to talk to each other about COVID-19 vaccination and climate change.

Who is the study for?

This trial is for U.S. residents over 18 who speak and read English, are aware of COVID-19 and the vaccine, and have a history of quality responses on Prolific's platform. Participants must consent to join.Check my eligibility

What is being tested?

The study is testing peer communication strategies aimed at educating others about COVID-19 vaccination and climate change issues through social diffusion interventions.See study design

What are the potential side effects?

Since this trial involves messaging strategies rather than medical interventions, there are no direct physical side effects. However, participants may experience stress or discomfort discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You know about COVID-19 and the vaccine for COVID-19.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Actions to promote climate change activism in social network

Actions to promote vaccine uptake in social network

Frequency of conversations about climate change

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: vaccineExperimental Treatment1 Intervention

Promotes COVID-19 vaccine uptake

Group II: climate changeActive Control1 Intervention

Promotes climate change activism

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Social diffusion intervention

2022

N/A

~600

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,116,330 Total Patients Enrolled

1 Trials studying Vaccine Hesitancy

2,058 Patients Enrolled for Vaccine Hesitancy

Carl A Latkin, Ph.D.Principal InvestigatorJohns Hopkins Bloomberg School of Public Health

1 Previous Clinical Trials

240 Total Patients Enrolled

Media Library

Social diffusion intervention (NA) Clinical Trial Eligibility Overview. Trial Name: NCT05530044 — N/A

Vaccine Hesitancy Research Study Groups: vaccine, climate change

Vaccine Hesitancy Clinical Trial 2023: Social diffusion intervention Highlights & Side Effects. Trial Name: NCT05530044 — N/A

Social diffusion intervention (NA) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05530044 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are enrolled in this research initiative?

"Affirmative. Clinicaltrials.gov states that the recruitment process for this trial is ongoing, after its initial posting on August 30th 2022 and subsequent editing on September 2nd 2022. The research team requires 600 participants from one site to complete the project."

Answered by AI

Is enrollment to this research trial still in progress?

"Affirmative, clinicaltrials.gov lists this medical investigation as actively seeking candidates. This study was initially posted on August 30th 2022 and updated most recently September 2nd 2022; it requires 600 volunteers from a single location to participate."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Messaging Strategies to Increase Peer Education on COVID-19 Vaccination and Climate Change

2022. "Messaging Strategies to Increase Peer Education on COVID-19 Vaccination and Climate Change". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05530044.